Janssen Inc.
12 meetings with public office holders, Sep 17, 2025 to Jul 23, 2026.
261 meetings on record since the registry opened in 2008.
Meetings over time
- Sep 2025: 1 meeting, with Ritu Banerjee, Greg Orencsak
- Oct 2025: 4 meetings, with Gary Xie, Iris Petten, Arianna Knoefel, Scott Reid, Elizabeth Wong
- Nov 2025: 0 meetings
- Dec 2025: 0 meetings
- Jan 2026: 0 meetings
- Feb 2026: 2 meetings, with Justine Frame, Dominic LeBlanc, Nasser Haidar, Janice Charette, Karim Bardeesy
- Mar 2026: 0 meetings
- Apr 2026: 4 meetings, with Marjorie Michel, Ritu Banerjee, Michelle Boudreau
- May 2026: 0 meetings
- Jun 2026: 0 meetings
- Jul 2026: 1 meeting, with Ritu Banerjee
Sep 2025peak 4 in a monthJul 2026
Hover or focus a month to see who was met.
What they lobby about
- Health12
- Industry12
- Economic Development11
- Intellectual Property9
- Research and Development9
- Science and Technology9
- International Development1
The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.
Who they met
Liberal3 met · 4 meetings
Conservative1 met · 1 meeting
Not in Arena's member list16 met · 23 meetings
- Ritu Banerjee
- Michelle Boudreau
- Justine Frame
- Arianna Knoefel
- Elizabeth Wong
- Gary Xie
- Greg Orencsak
- Hosai Zurmati Halim
- Iris Petten
- Janice Charette
- Manuela Tomic
- Martin Moen
- Nasser Haidar
- Ritu Banerjee
- Sandenga Yeba
- Shalene Curtis-Micallef
Health Canada (HC) (11) · Innovation, Science and Economic Development Canada (ISED) (7) · Privy Council Office (PCO) (3) · Senate of Canada (2) · Treasury Board Of Canada Secretariat (TBS) (2) · Global Affairs Canada (GAC) (2)
In their own words
- Canada's Innovation Agenda: ensuring that the life sciences industry is included and promoting awareness of and support for the full ecosystem from early stage research to commercialization and reimbursement.
- Canadian Drug Agency: the mandate and creation of a new Canadian Drug Agency and transition work to support pharmacare-related initiatives, including patient access and reimbursement framework.
- Development of Health Emergency Readiness Canada agency, and role in promoting development life sciences sector.
Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.